Pharmaceuticals
10 Bristol Myers Squibb finance leaders
These ten Bristol Myers Squibb finance leaders, including Bristol Myers Squibb's CFO, hold executive vice president, senior vice president and vice president roles in finance, accounting and treasury at the company. A reader can learn how CFOs and finance leaders approach planning, reporting and capital decisions in pharmaceutical businesses.
Professionals to explore
01—10Bob Owens
LinkedInExperience: Vice President, Chief Accountant · Bristol Myers Squibb
Vice President, Chief Accountant at Bristol Myers Squibb since 2008, a role the source lists at President/Vice President level in the Finance & Accounting department. The source listing shows only this role, so this profile suits questions about accounting leadership at the company.
Brandon Taverni
LinkedInExperience: VP, BD & Strategic Finance, CFO Support Lead · Bristol Myers Squibb
VP, BD & Strategic Finance, CFO Support Lead at Bristol Myers Squibb since April 2024. Former Executive Director, Strategic Finance & CFO Support Lead (2023–2024), Sr. Director, Strategic Finance Lead (2022–2023) and Sr. Director, R&D Finance Portfolio Reporting & Analysis (2021–2022) at Bristol Myers Squibb.
Caroline McKenna FCMA, CGMA
LinkedInExperience: Senior Vice President Finance, Global Product Development & Supply · Bristol Myers Squibb
Senior Vice President Finance, Global Product Development & Supply at Bristol Myers Squibb since April 2025, a role the source tags at Executive level. Former SVP and Finance Lead Global Manufacturing & Supply at Zoetis (2022–2025), and former Vice President Finance, Global Supply Chain Operations (2022) and Vice President Financial Planning & Analysis & Operational Finance (2020–2022) at Avantor.
David Elkins
LinkedInExperience: Executive Vice President and Chief Financial Officer, Head of Global Business Operations · Bristol Myers Squibb
Executive Vice President and Chief Financial Officer, Head of Global Business Operations at Bristol Myers Squibb since November 2019. The profile describes the role as sitting at the intersection of business and healthcare and helping steer the organization. The source listing shows only this role.
Keith Gaub
LinkedInExperience: Vice President & Assistant Treasurer · Bristol Myers Squibb
Vice President & Assistant Treasurer at Bristol Myers Squibb since March 2022, a role the source lists at President/Vice President level in the Finance & Accounting department. Former Investor Relations at Zoetis (2020–2022) and Capital Markets & Risk Management at Zoetis (2013–2022).
Kevin Dillon, CFA
LinkedInExperience: Senior Vice President - Head Corporate Finance & FP&A · Bristol Myers Squibb
Senior Vice President - Head Corporate Finance & FP&A at Bristol Myers Squibb since 2021; the profile lists corporate finance areas of CFP&A, treasury, strategic planning and M&A. Former Vice President, Assistant Treasurer (2018–2021), Senior Director, Corporate Development (M&A Group Lead) (2013–2018) and Director, Treasury-Capital Markets (2010–2013) at Pfizer.
Mark Blohm
LinkedInExperience: Vice President Finance · Bristol Myers Squibb
Vice President Finance at Bristol Myers Squibb since 2025. Former Vice President Finance - US Commercial FP&A (2024), Vice President Finance- Business Insights and Technology (2021–2024), Vice President Finance - Corporate FP&A (2019–2021) and Executive Director Finance - US Commercial Oncology FP&A (2015–2019) at Bristol Myers Squibb.
Michael Howley
LinkedInExperience: Vice President Finance European Markets · Bristol Myers Squibb
Vice President Finance European Markets at Bristol Myers Squibb since January 2024, based in Munich. Former Executive Director Finance Germany (2019–2023), Finance Director Germany (2014–2019), Senior Finance Director Europe HQ (2012–2014) and Finance Director Greece (2010–2012) at Bristol Myers Squibb.
Morgan Vlahakis
LinkedInExperience: Senior Vice President, Commercialization Finance · Bristol Myers Squibb
Senior Vice President, Commercialization Finance at Bristol Myers Squibb since February 2026, listed in the Finance & Accounting department. Former Vice President, US Commercial and Cell Therapy Finance (2025–2026), Vice President, Cell Therapy Finance (2024–2025), Vice President, WW Commercialization Analytics (2023–2024) and Vice President, WW Commercial Strategy & Forecasting (2022–2023) at Bristol Myers Squibb.
Phil Holzer, CPA, CGMA
LinkedInExperience: Senior Vice President & Controller · Bristol Myers Squibb
Senior Vice President & Controller at Bristol Myers Squibb since February 2024, a role the source lists in the Finance & Accounting department at Senior level. The source listing shows only this role, so this profile suits questions about controllership and financial reporting at the company.
Choose the right perspective
Match the person's finance area to your question, since corporate FP&A, controllership and accounting, treasury, commercialization finance and regional finance each answer different questions. For questions about one business area or market, favor the person whose title names it.
Questions to take into the conversation
- 01How does a pharmaceutical finance team balance spending on late-stage development against commercial launches?
- 02What does the controller's office need from business finance teams to close and report results reliably?
- 03How do regional finance leaders work with global FP&A when setting targets for their markets?
Reaching Bristol Myers Squibb finance leaders
How can I contact one of these Bristol Myers Squibb finance leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Bristol Myers Squibb, based on profile data retrieved on October 7, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Bristol Myers Squibb finance leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal